This is Gilead's drug that's received EUA (Emergency Use Authorization) status from the FDA, but is observed in many clinical settings to only be mildly effective if at all, sometimes not even better than placebo.
Edit - Sources for EUAs: https://www.gilead.com/news-and-press/press-room/press-releases/2020/5/gileads-investigational-antiviral-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-covid19 , https://www.gilead.com/news-and-press/press-room/press-releases/2020/8/gileads-investigational-antiviral-veklury-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-p
Edit 2 - Sources for "mixed" efficacy: https://www.reuters.com/article/us-health-coronavirus-remdesivir/gilead-fda-could-expand-remdesivir-use-despite-mixed-data-idUSKBN25H2CT , https://www.reuters.com/article/health-coronavirus-remdesivir/gilead-study-remdesivir-has-marginal-benefit-for-moderate-covid-patients-idUSL1N2FN17E
Before heading to Walter Reed, he took one dose of Regeneron's monoclonal antibody cocktail: https://twitter.com/PressSec/status/1312122950133272576, which has been shown to reduce viral levels in non-hospitalized patients: https://investor.regeneron.com/news-releases/news-release-details/regenerons-regn-cov2-antibody-cocktail-reduced-viral-levels-and
This is Gilead's drug that's received EUA (Emergency Use Authorization) status from the FDA, but is observed in many clinical settings to only be mildly effective if at all, sometimes not even better than placebo.
Edit - Sources for EUAs: https://www.gilead.com/news-and-press/press-room/press-releases/2020/5/gileads-investigational-antiviral-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-covid19 , https://www.gilead.com/news-and-press/press-room/press-releases/2020/8/gileads-investigational-antiviral-veklury-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-p
Edit 2 - Sources for "mixed" efficacy: https://www.reuters.com/article/us-health-coronavirus-remdesivir/gilead-fda-could-expand-remdesivir-use-despite-mixed-data-idUSKBN25H2CT , https://www.reuters.com/article/health-coronavirus-remdesivir/gilead-study-remdesivir-has-marginal-benefit-for-moderate-covid-patients-idUSL1N2FN17E
Before heading to Walter Reed, he took one dose of Regeneron's polyclonal antibody cocktail: https://twitter.com/PressSec/status/1312122950133272576, which has been shown to reduce viral levels in non-hospitalized patients: https://investor.regeneron.com/news-releases/news-release-details/regenerons-regn-cov2-antibody-cocktail-reduced-viral-levels-and
This is Gilead's drug that's received EUA (Emergency Use Authorization) status from the FDA, but is observed in many clinical settings to only be mildly effective if at all, sometimes not even better than placebo.
Edit - Sources for EUAs: https://www.gilead.com/news-and-press/press-room/press-releases/2020/5/gileads-investigational-antiviral-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-covid19 , https://www.gilead.com/news-and-press/press-room/press-releases/2020/8/gileads-investigational-antiviral-veklury-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-p
Edit 2 - Sources for "mixed" efficacy: https://www.reuters.com/article/us-health-coronavirus-remdesivir/gilead-fda-could-expand-remdesivir-use-despite-mixed-data-idUSKBN25H2CT , https://www.reuters.com/article/health-coronavirus-remdesivir/gilead-study-remdesivir-has-marginal-benefit-for-moderate-covid-patients-idUSL1N2FN17E
Before heading to Walter Reed, he took one dose of Regeneron's monoclonal antibody cocktail: https://twitter.com/PressSec/status/1312122950133272576, which has been shown to reduce viral levels in non-hospitalized patients: https://investor.regeneron.com/news-releases/news-release-details/regenerons-regn-cov2-antibody-cocktail-reduced-viral-levels-and
This is Gilead's drug that's received EUA (Emergency Use Authorization) status from the FDA, but is observed in many clinical settings to only be mildly effective if at all, sometimes not even better than placebo.
Edit - Sources for EUAs: https://www.gilead.com/news-and-press/press-room/press-releases/2020/5/gileads-investigational-antiviral-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-covid19 , https://www.gilead.com/news-and-press/press-room/press-releases/2020/8/gileads-investigational-antiviral-veklury-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-p
Edit 2 - Sources for "mixed" efficacy: https://www.reuters.com/article/us-health-coronavirus-remdesivir/gilead-fda-could-expand-remdesivir-use-despite-mixed-data-idUSKBN25H2CT , https://www.reuters.com/article/health-coronavirus-remdesivir/gilead-study-remdesivir-has-marginal-benefit-for-moderate-covid-patients-idUSL1N2FN17E
Before heading to Walter Reed, he took one dose of Regeneron's monoclonal antibody cocktail: https://twitter.com/PressSec/status/131212295013327257, which has been shown to reduce viral levels in non-hospitalized patients: https://investor.regeneron.com/news-releases/news-release-details/regenerons-regn-cov2-antibody-cocktail-reduced-viral-levels-and
This is Gilead's drug that's received EUA (Emergency Use Authorization) status from the FDA, but is observed in many clinical settings to only be mildly effective if at all, sometimes not even better than placebo.
Edit - Sources for EUAs: https://www.gilead.com/news-and-press/press-room/press-releases/2020/5/gileads-investigational-antiviral-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-covid19 , https://www.gilead.com/news-and-press/press-room/press-releases/2020/8/gileads-investigational-antiviral-veklury-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-p
Before heading to Walter Reed, he took one dose of Regeneron's monoclonal antibody cocktail: https://twitter.com/PressSec/status/131212295013327257, which has been shown to reduce viral levels in non-hospitalized patients: https://investor.regeneron.com/news-releases/news-release-details/regenerons-regn-cov2-antibody-cocktail-reduced-viral-levels-and
This is Gilead's drug that's received EUA (Emergency Use Authorization) status from the FDA, but is observed in many clinical settings to only be mildly effective if at all, sometimes not even better than placebo.
Sources for EUAs: https://www.gilead.com/news-and-press/press-room/press-releases/2020/5/gileads-investigational-antiviral-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-covid19 , https://www.gilead.com/news-and-press/press-room/press-releases/2020/8/gileads-investigational-antiviral-veklury-remdesivir-receives-us-food-and-drug-administration-emergency-use-authorization-for-the-treatment-of-p
Before heading to Walter Reed, he took one dose of Regeneron's monoclonal antibody cocktail: https://twitter.com/PressSec/status/131212295013327257, which has been shown to reduce viral levels in non-hospitalized patients: https://investor.regeneron.com/news-releases/news-release-details/regenerons-regn-cov2-antibody-cocktail-reduced-viral-levels-and